Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
04 11 2023
Historique:
received: 26 04 2023
accepted: 25 10 2023
medline: 6 11 2023
pubmed: 5 11 2023
entrez: 5 11 2023
Statut: epublish

Résumé

Clinical implementation of new prediction models requires evaluation of their utility in a broad range of intended use populations. Here we develop and validate ancestry-specific Polygenic Risk Scores (PRSs) for Coronary Artery Disease (CAD) using 29,389 individuals from diverse cohorts and genetic ancestry groups. The CAD PRSs outperform published scores with an average Odds Ratio per Standard Deviation of 1.57 (SD = 0.14) and identify between 12% and 24% of individuals with high genetic risk. Using this risk factor to reclassify borderline or intermediate 10 year Atherosclerotic Cardiovascular Disease (ASCVD) risk improves assessments for both CAD (Net Reclassification Improvement (NRI) = 13.14% (95% CI 9.23-17.06%)) and ASCVD (NRI = 10.70 (95% CI 7.35-14.05)) in an independent cohort of 9,691 individuals. Our analyses demonstrate that using PRSs as Risk Enhancers improves ASCVD risk assessments outlining an approach for guiding ASCVD prevention with genetic information.

Identifiants

pubmed: 37925478
doi: 10.1038/s41467-023-42897-w
pii: 10.1038/s41467-023-42897-w
pmc: PMC10625612
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7105

Informations de copyright

© 2023. The Author(s).

Références

Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Science. 2014 Feb 14;343(6172):747-751
pubmed: 24531965
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Br J Cancer. 2018 May;118(9):1262-1267
pubmed: 29581483
Nat Genet. 2022 Apr;54(4):450-458
pubmed: 35393596
Nat Genet. 2015 Oct;47(10):1121-1130
pubmed: 26343387
NPJ Precis Oncol. 2022 Apr 8;6(1):25
pubmed: 35396534
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2499-506
pubmed: 17954523
Circ Genom Precis Med. 2022 Oct;15(5):e003423
pubmed: 35904973
Nat Genet. 2013 Jan;45(1):25-33
pubmed: 23202125
Nat Genet. 2022 May;54(5):573-580
pubmed: 35513724
Genet Med. 2019 Dec;21(12):2765-2773
pubmed: 31147632
Nat Med. 2022 May;28(5):1006-1013
pubmed: 35437332
J Allergy Clin Immunol. 2022 Nov;150(5):1086-1096
pubmed: 35595084
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
J Am Heart Assoc. 2022 Jun 21;11(12):e025236
pubmed: 35699184
Nat Commun. 2018 Mar 7;9(1):989
pubmed: 29515099
Circ Genom Precis Med. 2021 Apr;14(2):e003304
pubmed: 33651632
Nat Genet. 2018 Nov;50(11):1600-1607
pubmed: 30297966
J Am Coll Cardiol. 2020 Jun 9;75(22):2769-2780
pubmed: 32498804
Front Psychiatry. 2020 Dec 14;11:557160
pubmed: 33381055
Am J Hum Genet. 2022 Jan 6;109(1):12-23
pubmed: 34995502
Nat Genet. 2023 Sep;55(9):1435-1439
pubmed: 37592023
JAMA Cardiol. 2023 Feb 1;8(2):130-137
pubmed: 36576811
Science. 2016 Dec 23;354(6319):
pubmed: 28008010
Mol Psychiatry. 2017 Oct;22(10):1376-1384
pubmed: 28937693
Am J Hum Genet. 2019 Dec 5;105(6):1213-1221
pubmed: 31761295
Circ Res. 2020 Apr 24;126(9):1159-1177
pubmed: 32324503
Science. 2022 Apr 15;376(6590):250-252
pubmed: 35420968
PLoS Genet. 2013 Mar;9(3):e1003348
pubmed: 23555274
Sci Data. 2023 Jan 31;10(1):64
pubmed: 36720882
Front Genet. 2021 Sep 17;12:690366
pubmed: 34650589
Nat Med. 2022 Jun;28(6):1163-1166
pubmed: 35654908
Cell Genom. 2022 Apr 13;2(4):None
pubmed: 35591975
Nat Genet. 2020 Dec;52(12):1355-1363
pubmed: 33199916
J Intern Med. 2002 Sep;252(3):247-54
pubmed: 12270005
Am J Epidemiol. 2002 Nov 1;156(9):871-81
pubmed: 12397006
Nat Genet. 2021 Oct;53(10):1415-1424
pubmed: 34594039
Nat Genet. 2017 Sep;49(9):1385-1391
pubmed: 28714975
Elife. 2020 Jan 30;9:
pubmed: 31999256
BMC Bioinformatics. 2015 Jan 16;16:4
pubmed: 25592880
PLoS Genet. 2021 Sep 16;17(9):e1009670
pubmed: 34529658
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
PLoS One. 2022 Apr 8;17(4):e0266384
pubmed: 35395044
Biol Psychiatry. 2019 Jul 15;86(2):97-109
pubmed: 30737014
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Genet Epidemiol. 2017 Dec;41(8):811-823
pubmed: 29110330
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Eur Heart J. 2023 Jan 7;44(2):89-99
pubmed: 36478054
JAMA. 2020 Feb 18;323(7):636-645
pubmed: 32068818
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Circulation. 2022 Aug 23;146(8):e93-e118
pubmed: 35862132
Circ Genom Precis Med. 2020 Jun;13(3):e002670
pubmed: 32469254
BMJ. 2023 Feb 28;380:e073149
pubmed: 36854461
Nat Med. 2023 Jul;29(7):1793-1803
pubmed: 37414900
Nat Med. 2022 Feb;28(2):243-250
pubmed: 35145307
Circulation. 2021 Aug 10;144(6):410-422
pubmed: 34247495
Biometrics. 2022 Jun;78(2):499-511
pubmed: 33786811
Nat Protoc. 2020 Sep;15(9):2759-2772
pubmed: 32709988
J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209
pubmed: 30423391
Cell. 2019 Apr 18;177(3):587-596.e9
pubmed: 31002795
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Eur Heart J. 2022 May 7;43(18):1702-1711
pubmed: 35195259
Nat Genet. 2021 Nov;53(11):1616-1621
pubmed: 34737426
Circulation. 2021 Apr 6;143(14):1452-1454
pubmed: 33677976
Elife. 2016 Jun 21;5:
pubmed: 27324836

Auteurs

George B Busby (GB)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA. george@allelica.com.

Scott Kulm (S)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA.

Alessandro Bolli (A)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA.

Jen Kintzle (J)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA.

Paolo Di Domenico (PD)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA.

Giordano Bottà (G)

Allelica Inc, 447 Broadway, New York, NY, 10013, USA. giordano@allelica.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH